The effect of change in PSA velocity on overall survival (OS) in men with biochemically recurrent prostate cancer (BRPC) treated with nonhormonal agents: Combined analysis of four phase 2 trials.
Daniel L. Suzman
No relevant relationships to disclose
Marianna Zahurak
No relevant relationships to disclose
Michael Anthony Carducci
No relevant relationships to disclose
Mario A. Eisenberger
No relevant relationships to disclose
Emmanuel S. Antonarakis
No relevant relationships to disclose